Solesence (NASDAQ:SLSN – Get Free Report) is one of 55 public companies in the “Personal Care Products” industry, but how does it compare to its peers? We will compare Solesence to similar businesses based on the strength of its analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends.
Earnings and Valuation
This table compares Solesence and its peers top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Solesence | $60.40 million | $1.79 million | 102.00 |
| Solesence Competitors | $8.23 billion | $1.08 billion | 2.16 |
Solesence’s peers have higher revenue and earnings than Solesence. Solesence is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Solesence | 1 | 0 | 0 | 0 | 1.00 |
| Solesence Competitors | 840 | 2809 | 3570 | 213 | 2.42 |
As a group, “Personal Care Products” companies have a potential upside of 7.40%. Given Solesence’s peers stronger consensus rating and higher probable upside, analysts plainly believe Solesence has less favorable growth aspects than its peers.
Volatility & Risk
Solesence has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Comparatively, Solesence’s peers have a beta of 0.79, suggesting that their average stock price is 21% less volatile than the S&P 500.
Profitability
This table compares Solesence and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Solesence | 1.56% | 5.39% | 1.78% |
| Solesence Competitors | -6.04% | -64.95% | 0.23% |
Institutional and Insider Ownership
70.2% of Solesence shares are owned by institutional investors. Comparatively, 49.0% of shares of all “Personal Care Products” companies are owned by institutional investors. 4.8% of Solesence shares are owned by company insiders. Comparatively, 12.3% of shares of all “Personal Care Products” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Solesence peers beat Solesence on 7 of the 13 factors compared.
Solesence Company Profile
Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.
Receive News & Ratings for Solesence Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solesence and related companies with MarketBeat.com's FREE daily email newsletter.
